Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.

Standard

Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. / Deuse, Tobias; Stubendorff, Mandy; Tang-Quan, Karis; Phillips, Neil; Kay, Mark A; Eiermann, Thomas; Phan, Thang T; Volk, Hans-Dieter; Reichenspurner, Hermann; Robbins, Robert C; Schrepfer, Sonja.

in: CELL TRANSPLANT, Jahrgang 20, Nr. 5, 5, 2011, S. 655-667.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Deuse, T, Stubendorff, M, Tang-Quan, K, Phillips, N, Kay, MA, Eiermann, T, Phan, TT, Volk, H-D, Reichenspurner, H, Robbins, RC & Schrepfer, S 2011, 'Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.', CELL TRANSPLANT, Jg. 20, Nr. 5, 5, S. 655-667. <http://www.ncbi.nlm.nih.gov/pubmed/21054940?dopt=Citation>

APA

Deuse, T., Stubendorff, M., Tang-Quan, K., Phillips, N., Kay, M. A., Eiermann, T., Phan, T. T., Volk, H-D., Reichenspurner, H., Robbins, R. C., & Schrepfer, S. (2011). Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. CELL TRANSPLANT, 20(5), 655-667. [5]. http://www.ncbi.nlm.nih.gov/pubmed/21054940?dopt=Citation

Vancouver

Deuse T, Stubendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T et al. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. CELL TRANSPLANT. 2011;20(5):655-667. 5.

Bibtex

@article{28bcfc1ff1414fb6a78eaec59ea3bc70,
title = "Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.",
abstract = "We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients >65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-? and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-? at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-? and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-? (>50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-? environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.",
author = "Tobias Deuse and Mandy Stubendorff and Karis Tang-Quan and Neil Phillips and Kay, {Mark A} and Thomas Eiermann and Phan, {Thang T} and Hans-Dieter Volk and Hermann Reichenspurner and Robbins, {Robert C} and Sonja Schrepfer",
year = "2011",
language = "English",
volume = "20",
pages = "655--667",
journal = "CELL TRANSPLANT",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "5",

}

RIS

TY - JOUR

T1 - Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.

AU - Deuse, Tobias

AU - Stubendorff, Mandy

AU - Tang-Quan, Karis

AU - Phillips, Neil

AU - Kay, Mark A

AU - Eiermann, Thomas

AU - Phan, Thang T

AU - Volk, Hans-Dieter

AU - Reichenspurner, Hermann

AU - Robbins, Robert C

AU - Schrepfer, Sonja

PY - 2011

Y1 - 2011

N2 - We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients >65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-? and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-? at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-? and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-? (>50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-? environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.

AB - We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients >65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-? and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-? at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-? and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-? (>50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-? environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.

M3 - SCORING: Journal article

VL - 20

SP - 655

EP - 667

JO - CELL TRANSPLANT

JF - CELL TRANSPLANT

SN - 0963-6897

IS - 5

M1 - 5

ER -